Neil H. Bander
NewYork–Presbyterian Hospital(US)Cornell University(US)New York Hospital Queens(US)Presbyterian Hospital(US)Weill Cornell Medicine(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, Mass Spectrometry Techniques and Applications, Medical Imaging Techniques and Applications
Most-Cited Works
- → Renal-Cell Carcinoma(1996)2,242 cited
- → Mutations of the VHL tumour suppressor gene in renal carcinoma(1994)1,733 cited
- → Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile(2012)1,113 cited
- Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.(1999)
- → Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse(1989)673 cited
- → The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer(2014)629 cited